PMC:7060195 / 2270-2579
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
67 | 109-119 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
72 | 170-181 | Disease | denotes | lung injury | MESH:D055370 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T2 | 170-174 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
T3 | 202-212 | Body_part | denotes | neutrophil | http://purl.org/sig/ont/fma/fma62860 |
T4 | 253-261 | Body_part | denotes | cytokine | http://purl.org/sig/ont/fma/fma84050 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T3 | 170-174 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
LitCovid_AGAC
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
p10944s31 | 183-193 | NegReg | denotes | diminished |
p10944s33 | 202-219 | CPA | denotes | neutrophil influx |
p10944s41 | 253-273 | MPA | denotes | cytokine expressions |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T20 | 109-117 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T21 | 175-181 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T16 | 30-35 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T17 | 170-174 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
T18 | 170-174 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 133-145 | http://purl.obolibrary.org/obo/GO_0009405 | denotes | pathogenesis |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T18 | 0-309 | Sentence | denotes | The development of attenuated-virus vaccines is also possible by carefully screening the serially propagated SARS-CoV-2 with reduced pathogenesis such as induced minimal lung injury, diminished limited neutrophil influx, and increased anti-inflammatory cytokine expressions compared with the wild-type virus9. |